Wednesday, January 31, 2024 9:08:20 PM
Volume: | 83,664 |
Day Range: | 1.0501 - 1.12 |
Bid: | 1.06 |
Ask: | 10.00 |
Last Trade Time: | 7:39:55 PM EST |
Total Trades: | 194 |
Recent NRSN News
- NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement • PR Newswire (US) • 01/06/2025 02:00:00 PM
- NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS • PR Newswire (US) • 12/23/2024 02:00:00 PM
- NeuroSense Provides Business Update and Third Quarter 2024 Financial Results • PR Newswire (US) • 12/18/2024 03:25:00 PM
- NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC • PR Newswire (US) • 12/11/2024 02:25:00 PM
- NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS • PR Newswire (US) • 12/04/2024 01:30:00 PM
- NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price • PR Newswire (US) • 12/02/2024 01:30:00 PM
- NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND • PR Newswire (US) • 11/21/2024 02:20:00 PM
- NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission • PR Newswire (US) • 10/28/2024 12:30:00 PM
- New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients • PR Newswire (US) • 10/24/2024 12:30:00 PM
- NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates • PR Newswire (US) • 10/15/2024 01:15:00 PM
- NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada • PR Newswire (US) • 10/09/2024 01:00:00 PM
- NeuroSense Therapeutics Announces Acceptance of Two PrimeC Abstracts at the 2024 NEALS Annual Meeting • PR Newswire (US) • 10/07/2024 01:00:00 PM
- NeuroSense Therapeutics Granted Key U.S. Patent for Novel PrimeC Formulation, its Lead Asset for ALS and Alzheimer's • PR Newswire (US) • 09/24/2024 01:05:00 PM
- NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule • PR Newswire (US) • 09/24/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 09:00:06 PM
- NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification • PR Newswire (US) • 08/30/2024 08:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2024 11:05:11 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/26/2024 12:00:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 08:06:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2024 08:05:36 PM
- NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price • PR Newswire (US) • 08/07/2024 06:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 01:00:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2024 01:24:12 PM
- NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial • PR Newswire (US) • 08/01/2024 01:15:00 PM
- NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression • PR Newswire (US) • 07/09/2024 01:27:00 PM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • ZEFI • Jan 15, 2025 7:33 AM